RICHARD COLLINS: Open Payments
NPI 1528081197 · ELKTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 23 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $155 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Lilly USA, LLC | 4 | $65 |
| PFIZER INC. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Novo Nordisk Inc | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $31 |
| Tactile Systems Technology Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: FARXIGA, NURTEC ODT, MOUNJARO, JARDIANCE, XIFAXAN, Flexitouch Plus, The Cologuard Plus Collection Kit, Wegovy.
Industry payments across MD — which companies pay providers there.
